「TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer」の関連論文
-
Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer
-
Prognostic factors for bone metastases from head and neck squamous cell carcinoma: A case series of 97 patients
-
Greater reductions in blood flow after anti-angiogenic treatment in non-small cell lung cancer patients are associated with shorter progression-free survival
-
Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion
-
HTR3A is correlated with unfavorable histology and promotes proliferation through ERK phosphorylation in lung adenocarcinoma
-
NOTCH3 limits the epithelial-mesenchymal transition and predicts a favorable clinical outcome in esophageal cancer
-
Immunoscore signatures in surgical specimens and tumor-infiltrating lymphocytes in pretreatment biopsy predict treatment efficacy and survival in esophageal cancer
-
Circulating tumor HPV DNA complements PET-CT in guiding management after radiotherapy in HPV-related squamous cell carcinoma of the head and neck
-
Periostin secreted by activated fibroblasts in idiopathic pulmonary fibrosis promotes tumorigenesis of non-small cell lung cancer
-
Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma
-
Dipeptidyl Peptidase 9 Increases Chemoresistance and is an Indicator of Poor Prognosis in Colorectal Cancer
-
Inhibition of c-MET reverses radiation-induced malignant potential in pancreatic cancer
-
Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinoma
-
Heterogeneity of Treg/Th17 According to Cancer Progression and Modification in Biliary Tract Cancers via Self‑Producing Cytokines
-
Enhanced humoral immunity in breast cancer patients with high serum concentration of anti-HER2 autoantibody
-
An immature inhibin‐α‐expressing subpopulation of ovarian clear cell carcinoma cells is related to an unfavorable prognosis
-
Local hyperthermia combined with CTLA-4 blockade induces both local and abscopal effects in a murine breast cancer model
-
Fragmentation of cell-free DNA is induced by upper-tract urothelial carcinoma-associated systemic inflammation
-
Detection of ctDNA with Personalized Molecular Barcode NGS and Its Clinical Significance in Patients with Early Breast Cancer
-
Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinoma
-
Periostin Short Fragment with Exon 17 via Aberrant Alternative Splicing Is Required for Breast Cancer Growth and Metastasis
-
Vitamin D Supplementation is a Promising Therapy for Pancreatic Ductal Adenocarcinoma in Conjunction with Current Chemoradiation Therapy
-
Heterogenous chemosensitivity of a panel of organoid lines derived from small cell neuroendocrine carcinoma of the uterine cervix
-
Impact of sarcopenia in patients with advanced or recurrent colorectal cancer treated with regorafenib
-
Specific activation of glycolytic enzyme enolase 2 in BRAF V600E-mutated colorectal cancer
-
Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens
-
The meiosis-specific cohesin component stromal antigen 3 promotes cell migration and chemotherapeutic resistance in colorectal cancer
-
Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells
-
Knock-in mice bearing constitutively active αIIb(R990W) mutation develop macrothrombocytopenia with severe platelet dysfunction
-
Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas : identifying predictors of 50% volume reduction
-
Development of Prediction Model Including MicroRNA Expression for Sentinel Lymph Node Metastasis in ER-Positive and HER2-Negative Breast Cancer
-
Endometrial galectin-3 causes endometriosis by supporting eutopic endometrial cell survival and engraftment in the peritoneal cavity
-
Therapeutic potential of combination therapy of soluble VEGF receptor 1 and conventional chemotherapy for ovarian cancer growth
-
RNF213 p.R4810K variant carriers with intracranial arterial stenosis have a low atherosclerotic burden
-
Initial treatment response to transarterial chemoembolization as a predictive factor for Child-Pugh class deterioration prior to refractoriness in hepatocellular carcinoma
-
The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice
-
Targeted therapy for drug-tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours
-
Comparison of the multigene panel test and OncoScan™ for the determination of HER2 amplification in breast cancer
-
Long-term Outcomes of Radiation Therapy for Prostate Cancer in Elderly Patients Aged ≥75 Years
-
D-Serine is useful for the diagnosis of chronic kidney disease and promotes kidney remodeling
-
Disparity of Cervical Cancer Risk in Young Japanese Women: Bipolarized Status of HPV Vaccination and Cancer Screening
-
The Effect of Chemotherapy on Stroke Risk in Cancer Patients
-
miR-4711-5p regulates cancer stemness and cell cycle progression via KLF5, MDM2 and TFDP1 in colon cancer cells
-
Suppression of autophagy promotes fibroblast activation in p53-deficient colorectal cancer cells
-
Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan : A nationwide case-control study
-
PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer
-
Clinical importance of the expression of CD4+CD8+ T cells in renal cell carcinoma
-
Stereotactic Body Radiotherapy Using CyberKnife® for Localized Low- and Intermediate-risk Prostate Cancer: Initial Report on a Phase I/II Trial
-
Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer
-
Usefulness of immunohistochemistry to distinguish between secretory carcinoma and acinic cell carcinoma in the salivary gland